Back
ProShares Ultra Nasdaq Biotechnology Vs. Direxion Daily Cld Cmptng Bl 2X Shs ETF Industry Stock Comparison
Sell
44
BIB
ProShares Ultra Nasdaq Biotechnology
Last Price:
68.77
Seasonality Move:
2.56%
Buy
61
CLDL
Direxion Daily Cld Cmptng Bl 2X Shs ETF
Last Price:
10.00
Seasonality Move:
-16.18%
Sell
44
ProShares Ultra Nasdaq Biotechnology (BIB)
is a Sell
Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?
- The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $66.68. The Score for BIB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
61
Direxion Daily Cld Cmptng Bl 2X Shs ETF (CLDL)
is a Buy
Is Direxion Daily Cld Cmptng Bl 2X Shs ETF a Buy, Sell or Hold?
- The current Direxion Daily Cld Cmptng Bl 2X Shs ETF [CLDL] share price is $9.52. The Score for CLDL is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- CLDL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIB Stock Price Chart
What is ProShares Ultra Nasdaq Biotechnology's stock price today?
-
The ProShares Ultra Nasdaq Biotechnology share price today is $66.68
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.
CLDL Stock Price Chart
What is Direxion Daily Cld Cmptng Bl 2X Shs ETF's stock price today?
-
The Direxion Daily Cld Cmptng Bl 2X Shs ETF share price today is $9.52
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDL is experiencing slight buying pressure.
BIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.56 | Buy |
| Relative Strength Index (14 RSI): | 55.48 | Buy |
| Chaikin Money Flow: | -8699 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (64.16 - 67.46) | Buy |
| Bollinger Bands (100): | (56.44 - 65.98) | Buy |
CLDL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 53.36 | Buy |
| Chaikin Money Flow: | 743 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (9.13 - 9.69) | Buy |
| Bollinger Bands (100): | (8.78 - 9.88) | Buy |
BIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 65.98 | Buy |
| 20-day SMA: | 66.07 | Buy |
| 50-day SMA: | 65.28 | Buy |
| 200-day SMA: | 58.39 | Buy |
| 8-day EMA: | 66.31 | Buy |
| 20-day EMA: | 65.73 | Buy |
| 50-day EMA: | 64.37 | Buy |
| 200-day EMA: | 59.12 | Buy |
CLDL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.48 | Buy |
| 20-day SMA: | 9.48 | Buy |
| 50-day SMA: | 9.24 | Buy |
| 200-day SMA: | 10.15 | Sell |
| 8-day EMA: | 9.51 | Buy |
| 20-day EMA: | 9.41 | Buy |
| 50-day EMA: | 9.33 | Buy |
| 200-day EMA: | 9.54 | Sell |
ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Direxion Daily Cld Cmptng Bl 2X Shs ETF Earnings Growth & CLDL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares Ultra Nasdaq Biotechnology Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Direxion Daily Cld Cmptng Bl 2X Shs ETF Technical Analysis
| Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||